Advancing Biopharma R&D, Business Analytics, and Decision Making

In today’s ever-changing landscape of pharmaceutical R&D, drug development program and portfolio management, portfolio prioritization, capacity management, resource forecasting, risk mitigation, and strategic decision-making are paramount.  Cambridge Healthtech Institute’s Biopharma Strategy Series presents Executive Decision Making for Pharma and Biotech offers a comprehensive platform for high-level discussions, interactive sessions, networking opportunities, breakout roundtables, and personalized 1:1 meetings. Attendees will leave with new tools and organizational strategies to optimize project planning, portfolio insights and decision making; and align resource planning, allocation, and capacity management with portfolio prioritization.